CTI BioPharma Statistics
Total Valuation
NXGN has a market cap or net worth of $2.01 million. The enterprise value is $2.03 million.
| Market Cap | 2.01M |
| Enterprise Value | 2.03M |
Important Dates
The next confirmed earnings date is Thursday, August 28, 2025, after market close.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NXGN has 11.54 million shares outstanding. The number of shares has increased by 15.90% in one year.
| Current Share Class | 11.54M |
| Shares Outstanding | 11.54M |
| Shares Change (YoY) | +15.90% |
| Shares Change (QoQ) | +20.30% |
| Owned by Insiders (%) | 9.36% |
| Owned by Institutions (%) | 9.01% |
| Float | 10.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 2.12 |
| PB Ratio | -2.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.51 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.41 |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -203.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -728.92% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 207.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$447,702 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.52% in the last 52 weeks. The beta is 0.99, so NXGN's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +18.52% |
| 50-Day Moving Average | 23.51 |
| 200-Day Moving Average | 18.67 |
| Relative Strength Index (RSI) | 82.49 |
| Average Volume (20 Days) | 837,374 |
Short Selling Information
The latest short interest is 4.84 million, so 7.21% of the outstanding shares have been sold short.
| Short Interest | 4.84M |
| Short Previous Month | 5.10M |
| Short % of Shares Out | 7.21% |
| Short % of Float | 8.85% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.34M |
| Pretax Income | -1.34M |
| Net Income | -1.34M |
| EBITDA | -1.31M |
| EBIT | -1.34M |
| Earnings Per Share (EPS) | -$0.16 |
Balance Sheet
The company has $9,609 in cash and $60,950 in debt, giving a net cash position of -$51,341 or -$0.00 per share.
| Cash & Cash Equivalents | 9,609 |
| Total Debt | 60,950 |
| Net Cash | -51,341 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | -676,770 |
| Book Value Per Share | -0.06 |
| Working Capital | -739,917 |
Cash Flow
In the last 12 months, operating cash flow was -$566,126 and capital expenditures -$28,004, giving a free cash flow of -$594,130.
| Operating Cash Flow | -566,126 |
| Capital Expenditures | -28,004 |
| Free Cash Flow | -594,130 |
| FCF Per Share | -$0.05 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NXGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.90% |
| Shareholder Yield | -15.90% |
| Earnings Yield | -66.93% |
| FCF Yield | -29.61% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | -8.19% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 7.94% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 3, 2023. It was a reverse split with a ratio of 0.1666666667.
| Last Split Date | Sep 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1666666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |